Sagamore Investments

Neat Limited, founded in 2015 and based in Wan Chai, Hong Kong, operates a financial application that enables users to open mobile current accounts. The company provides a prepaid MasterCard known as the Neat Card, which facilitates payments in multiple currencies at various merchants globally. Neat offers tailored products for businesses, including dedicated Hong Kong bank account numbers, an online finance management dashboard, and expense cards for employees. For personal users, Neat provides mobile current accounts, ATM cards, and online money transfer capabilities. Designed with entrepreneurs in mind, Neat aims to offer a modern alternative to traditional banking, addressing the needs of a globalized economy and supporting seamless international business transactions.

Neat Limited, founded in 2015 and based in Wan Chai, Hong Kong, operates a financial application that enables users to open mobile current accounts. The company provides a prepaid MasterCard known as the Neat Card, which facilitates payments in multiple currencies at various merchants globally. Neat offers tailored products for businesses, including dedicated Hong Kong bank account numbers, an online finance management dashboard, and expense cards for employees. For personal users, Neat provides mobile current accounts, ATM cards, and online money transfer capabilities. Designed with entrepreneurs in mind, Neat aims to offer a modern alternative to traditional banking, addressing the needs of a globalized economy and supporting seamless international business transactions.

Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to developing therapies for diseases associated with mitochondrial dysfunction, which includes both rare genetic disorders and common age-related conditions. The company's lead product candidate, Elamipretide, aims to address these health issues, while additional candidates like SBT-20 and SBT-272 are being explored for their potential benefits in stabilizing mitochondrial function and treating neurodegenerative diseases, respectively. Founded in 2006 and based in George Town, Cayman Islands, Stealth BioTherapeutics collaborates with patients and advocacy groups to deepen its understanding of the challenges faced by those with mitochondrial diseases and to raise awareness of their therapeutic programs.

Wecash was founded in October of 2013 and is reshaping the way customers around the world interact with finance. To date, Wecash has served over 160 million users worldwide and raised almost US$300 million in equity financing. As an established fintech unicorn, Wecash aims to create a new digital banking, spending and saving experience in Europe, Brazil and Southeast Asia.

Accion is a global nonprofit organization founded in 1961 and headquartered in Cambridge, Massachusetts, focused on enhancing financial inclusion for underserved populations. The organization partners with financial service providers to deliver high-quality, affordable financial solutions that benefit individuals, small businesses, and communities. Accion's initiatives include providing advisory services, targeted coaching, and governance support for startups, particularly in the fintech sector. Through its investment initiative, Venture Lab, Accion invests in early-stage fintech startups that leverage innovative technologies and business models to improve access to financial services. Venture Lab offers both capital and strategic support, helping these startups scale their operations and enhance their impact. Accion's mission is to create a financially inclusive world by challenging industry norms and engaging with leaders and regulators to foster a more equitable financial landscape.